assessment of ketamine uropathy
Clicks: 197
ID: 189524
2015
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
197 views
40 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #121 of 280 articles by views in acta crystallographica section e
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 280 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
A group of experts on lower urinary tract dysfunction and cystitis met together to make a consensus report on the assessment of ketamine uropathy (KU) which encompasses ketamine cystitis.
Essential tests, which should be performed in all KU patients, are (1) detailed history taking with structured questionnaire, (2) physical examination, (3) urine tests including test strip biochemistry and sediments analysis, urine culture, and cytology, (4) blood tests including complete blood cell counts with differential counts, liver and renal function tests, IgE, HIV, VDRL, (5) urological tests including uroflowmetry and post void residual urine volume and renosonography.
Optional tests, which will be performed in selective cases, are (1) bladder diary for 48-72 hours, (2) bladder wall thickness by ultrasound, (3) upper tract evaluation with excretory urography, computed tomography of abdomen, diuretic renal scan, (4) lower urinary tract evaluation with cystoscopy, voiding cystography, urodynamics or videourodynamics, (5) bladder and/or ureteral biopsy, (6) abdominal echo and/or gastroendoscope. Optional tests are usually indicated when essential tests disclose abnormal findings.
Using the standardized tools to assess patients with ketamine abuse, patients characteristics can be clarified and different therapeutic strategies for ketamine uropathy can be compared in the future.
| Reference Key |
yang2015urologicalassessment
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Stephen S. Yang;Chun-Hsien Wu;Judy Yi-Ju Chen;Shang-Jen Chang;M.Y. Jang;W.J. Wu;Y.S. Ruan;S.Y. Li;J.S. Wu;Y.C. Chung;W.J. Li;Y.H. Li;Y.C. Tang;K.H. Shen;W.Y. Lin;J.S. Chen;M.H. Lee;M.H. Chen;J.L. Zou;J.S. Jhang;J.S. Syu;S.S. Yang;S.J. Chang;A.T.L. Lin;Y.H. Fan;E. Meng;Y.J. Syu;H.J. Yu;Y.C. Guo;J.S. Ye;Y.J. Wang;J.F. Jhang;Y.H. Jiang;H.C. Kuo |
| Journal | acta crystallographica section e |
| Year | 2015 |
| DOI |
10.1016/j.urols.2015.08.010
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.